Budúce P/E spoločnosti Intercept Pharmaceuticals Inc
Aká je hodnota metriky Budúce P/E spoločnosti Intercept Pharmaceuticals Inc?
Hodnota metriky Budúce P/E spoločnosti Intercept Pharmaceuticals Inc je -5.54
Aká je definícia metriky Budúce P/E?
Budúci pomer P/E (Forward price to earnings ratio) vyjadruje pomer súčasnej ceny a odhadovaného zisku na akciu za ďalších 12 mesiacov.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Budúce P/E spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Intercept Pharmaceuticals Inc
Čomu sa venuje spoločnosť Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Firmy s metrikou budúce p/e podobnou spoločnosti Intercept Pharmaceuticals Inc
- Hodnota metriky Budúce P/E spoločnosti Allot Ltd je -5.58
- Hodnota metriky Budúce P/E spoločnosti Rubicon Minerals je -5.58
- Hodnota metriky Budúce P/E spoločnosti Recro Pharma Inc je -5.58
- Hodnota metriky Budúce P/E spoločnosti Nephros Inc je -5.56
- Hodnota metriky Budúce P/E spoločnosti Atossa Therapeutics Inc je -5.56
- Hodnota metriky Budúce P/E spoločnosti Avinger Inc je -5.55
- Hodnota metriky Budúce P/E spoločnosti Intercept Pharmaceuticals Inc je -5.54
- Hodnota metriky Budúce P/E spoločnosti Opko Health Inc je -5.52
- Hodnota metriky Budúce P/E spoločnosti Capstone Turbine je -5.44
- Hodnota metriky Budúce P/E spoločnosti Hookipa Pharma Inc je -5.44
- Hodnota metriky Budúce P/E spoločnosti Avivagen je -5.40
- Hodnota metriky Budúce P/E spoločnosti Carmat SA je -5.38
- Hodnota metriky Budúce P/E spoločnosti Vroom je -5.38